Safety of echocardiographic contrast in hospitalized patients with pulmonary hypertension: A multi-center study

European Heart Journal Cardiovascular Imaging

Volumn 13, Issue 10, 2012, Pages 857-862

  Wever Pinzon, Omar ^a   Suma, Valentin ^b   Ahuja, Ameeta ^a   Romero, Jorge ^a   Sareen, Nishtha ^c   Henry, Sonia A ^b   De Benedetti Zunino, Maria ^a   Chaudhry, Farhan F ^a   Suryadevara, Ramya S ^a   Sherrid, Mark V ^a   Chaudhry, Farooq A ^a  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERFLUTREN;

AGED; ANAPHYLAXIS; ARTICLE; BODY MASS; BRAIN ISCHEMIA; CONTRAST ECHOCARDIOGRAPHY; CONVULSION; DISEASE SEVERITY; DRUG FATALITY; FAINTNESS; FEMALE; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HOSPITAL PATIENT; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PATIENT SAFETY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STRESS ECHOCARDIOGRAPHY; SYSTOLIC BLOOD PRESSURE; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; CONTRAST MEDIA; ECHOCARDIOGRAPHY; FEMALE; FLUOROCARBONS; HOSPITALIZATION; HUMANS; HYPERTENSION, PULMONARY; IATROGENIC DISEASE; MALE; PATIENT CARE; RETROSPECTIVE STUDIES; SAFETY;

EID: 84867525487     PISSN: 20472404     EISSN: None     Source Type: Journal    
DOI: 10.1093/ehjci/jes057     Document Type: Article

References (34)

1. Mulvagh SL, Rakowski H, Vannan MA, Abdelmoneim SS, Becher H, Bierig SM et al. American Society of Echocardiography Consensus Statement on the Clinical Applications of Ultrasonic Contrast Agents in Echocardiography. J Am Soc Echocardiogr 2008;21:1179-201.
2. Hundley WG, Kizilbash AM, Afridi I, Franco F, Peshock RM, Grayburn PA. Administration of intravenous perfluorocarbon contrast agent improves echocardiographic determination of left ventricular volumes and ejection fraction: comparison with cine magnetic resonance imaging. J Am Coll Cardiol 1998;32: 1426-32.
3. Thompson HL, Basmadijian AJ, Rainbird AJ, Razavi M, Avierinos JF, Pellikka PA et al. Contrast echocardiography improves the accuracy and reproducibility of left ventricular remodeling measurements: a prospective; randomly assigned, blinded study. J Am Coll Cardiol 2001;38:867-75. (Pubitemid 32835766)
4. Plana JC, Mikati IA, Dokainish H, Lakkis N, Abukhalil J, Davis R et al. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease The OPTIMIZE Trial. JACC Cardiovasc Imaging 2008;1:145-52. (Pubitemid 351445398)
5. Dolan MS, Gala SS, Dodla S, Abdelmoneim SS, Xie F, Cloutier D et al. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 2009;53:32-8.
6. Reilly JP, Tunick PA, Timmermans RJ, Stein B, Rosenzweig BP, Kronzon I. Contrast echocardiography clarifies uninterpretable wall motion in intensive care unit patients. J Am Coll Cardiol 2000;35:485-90. (Pubitemid 30125542)
7. Thanigaraj S, Nease RF, Schechtman KB, Wade RL, Loslo S, Perez JE. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 2001;87:1430-2. (Pubitemid 32523039)
8. Yong Y, Wu D, Fernandes V, Kopelen HA, Shimoni S, Nagueh SF et al. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patients in the intensive care unit. Am J Cardiol 2002;89:711-8. (Pubitemid 34230568)
9. Kurt M, Shaikh KA, Peterson L, Kurrelmeyer KM, Shah G, Nagueh SF et al. Impact of Contrast Echocardiography on evaluation of ventricular function and clinical management in a large prospective cohort. J Am Coll Cardiol 2009;53:802-10.
10. U.S. FDA prescribing information for Definity approved on October 10, 2007. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2007/ 021064s007lbl.pdf. Accessed February 22, 2012.
11. Kusnetzky LL, Khalid A, Khumri TM, Moe TG, Jones PG, Main ML. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent. J Am Coll Cardiol 2008;51:1704-6.
12. Main ML, Ryan AC, Davis TE, Albano MP, Kusnetzky LL, Hibberd M. Acute mortality in hospitalized patients undergoing echocardiography with and without an ultrasound contrast agent (Multicenter Registry Results in 4,300,966 Consecutive Patients). Am J Cardiol 2008;102:1742-6.
13. Shaikh K, Chang SM, Peterson L, Rosendahl-Garcia K, Quinones MA, Nagueh SF et al. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol 2008;102: 1444-50.
14. Lantheus Medical Imaging. CARES (ContrastEchocArdiography Registry for Safety Surveillance): A prospective, phase IV, open-label, nonrandomized, multicenter, surveillance registry study to evaluate the safety of Definity in clinical practice. Study DMP115-415. Available at: www.clinicalstudyresults.org/ drugdetails/?company-id=110&sort=c.company-name&page=1&drug-id= 10197. Accessed December 8, 2011.
15. U.S. FDA prescribing information for Definity approved on May 12, 2008. Available at: http://www.accessdata.fda.gov/drugsatfda-docs/label/2008/ 021064s009lbl.pdf Accessed February 22, 2012.
16. Lantheus Medical Imaging announces FDA approved revised indications and revised boxed warning to the U.S. Prescribing Information for Definity on October 27, 2011. Available at: http://www.asecho.org/files/ContrastZone/ DEFINITY%20LABEL%20MODIFICATIONS.pdf. Accessed February 22, 2012.
17. Tajik AJ, Seward JB, Hagler DJ, Mair DD, Lie JT. Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc 1978;53:271-303. (Pubitemid 8333780)
18. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by twodimensional echocardiography: American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
19. Bangalore S, Yao SS, Chaudhry FA. Prediction of myocardial infarction versus cardiac death by stress echocardiography. J Am Soc Echocardiogr 2009;22:261-7.
20. Yock PG, Popp RL. Noninvasive estimate of right ventricular systolic pressure by Doppler ultrasound in patients with tricuspid regurgitation. Circulation 1984;70: 657-62. (Pubitemid 14020664)
21. Kircher BJ, Himelman RB, Schiller NB. Noninvasive estimate of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66:493-6. (Pubitemid 20259386)
22. Lantheus Medical Imaging, Billerica, Massachusetts. Definity. U.S. Package Insert. Available at: http://www.definityimaging.com/prescribing-info. html. Accessed February 22, 2012.
23. Morel DR, Schwieger I, Hohn L, Terrettaz J, Llull JB, Cornioley YA et al. Human pharmacokinetics and safety evaluation of SonoVue(TM), a new contrast agent for ultrasound imaging. Invest Radiol 2000;35:80-85. (Pubitemid 30033610)
24. Yamaka Y, Niizeki K, Kim J, Entin PL, Wagner H, Wagner PD. Effects of Optison on pulmonary gas exchange and hemodynamics. Ultrasound Med Biol 2002;28: 1005-13. (Pubitemid 36158836)
25. Grayburn PA, Erickson JM, Escobar J, Womack L, Velasco CE. Peripheral intravenous myocardial contrast echocardiography using a 2% dodecafluoropentane emulsion: identification of myocardial risk area and infarct size in the canine model of ischemia. J Am Coll Cardiol 1995;26:1340-7.
26. De Chantal M, Amyot R, Diodati JG, LeBlanc AR, Pharand C. Absence of clinically significant increase in pulmonary artery pressure after intravenous Perflutren injection for myocardial perfusion imaging in pigs. J Am Soc Echocardiogr 2005;18: 1299-303. (Pubitemid 41821174)
27. Kirkton SD, Wagner H, Landicho MM, Struthers JJ, Busan N, Wagner PD. Effects of Imagent on pulmonary hemodynamics and gas exchange in dogs. Ultrasound Med Biol 2006;32:949-59. (Pubitemid 43903081)
28. Greener Y, Killam AL, Cornell ST, Osheroff MR, Wolford ST. Nonclinical safety assessment of intravenous Optison: A perfluoropropane (PFP)-filled albu microspheres contrast agent for ultrasonography. Int J Toxicol 1998;17:631-62. (Pubitemid 28487351)
29. Venus B, Smith RA, Patel C, Sandoval E. Hemodynamic and gas exchange alterations during intralipid infusion in patients with adult respiratory distress syndrome. Chest 1989;95:1278-81. (Pubitemid 19160157)
30. Kaplan RL, Sahn SA, Petty TL. Incidence and outcome of the acute respiratory distress syndrome in gram-negative sepsis. Arch Intern Med 1979;139:867-9. (Pubitemid 10150841)
31. Abdelmoneim SS, Bernier M, Scott CG, Dhoble A, Ness SAC, Hagen ME et al. Safety of contrast agent use during stress echocardiography in patients with elevated right ventricular systolic pressure: a cohort study. Circ Cardiovasc Imaging 2010;3:240-8.
32. Lantheus Study DMP-416. A phase IV, open-label safety evaluation of the effect of Definity on pulmonary artery hemodynamics in patients with normal and increased pulmonary artery pressure. Available at: http://www.clinicaltrials. gov/ct2/show/results/NCT00918866?term=lantheus+416&rank=1. Accessed December 14, 2011.
33. Jeon DS, Luo H, Iwami T, Miyamoto T, Brasch AV, Mirocha J et al. The usefulness of a 10% air-10% blood-80% saline mixture for contrast echocardiography: Doppler measurement of pulmonary artery systolic pressure. J Am Coll Cardiol 2002;39:124-9. (Pubitemid 34059871)
34. Dubourg O, Delorme G, Jondeau G, Chikli F, Clavier H, Valtier B et al. Simultaneous measurement of systolic pulmonary artery pressure by catheterization and contrast enhancement Doppler echocardiography. Arch Mal Coeur Vaiss 1993;86: 1721-7.